These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32547703)

  • 1. Carcinogenetic initiation contributed by EpCAM+ cancer cells in orthotopic HCC models of immunocompetent and athymic mice.
    Pandit H; Li Y; Zheng Q; Guo W; Yu Y; Li S; Martin RCG
    Oncotarget; 2020 Jun; 11(22):2047-2060. PubMed ID: 32547703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma.
    Pandit H; Li Y; Li X; Zhang W; Li S; Martin RCG
    BMC Cancer; 2018 Aug; 18(1):783. PubMed ID: 30075764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc finger protein X-linked promotes expansion of EpCAM
    Wang C; Fu SY; Wang MD; Yu WB; Cui QS; Wang HR; Huang H; Dong W; Zhang WW; Li PP; Lin C; Pan ZY; Yang Y; Wu MC; Zhou WP
    Mol Oncol; 2017 May; 11(5):455-469. PubMed ID: 28156061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EpCAM+ Liver Cancer Stem-Like Cells Exhibiting Autocrine Wnt Signaling Potentially Originate in Cirrhotic Patients.
    Khosla R; Rastogi A; Ramakrishna G; Pamecha V; Mukhopadhyay A; Vasudevan M; Sarin SK; Trehanpati N
    Stem Cells Transl Med; 2017 Mar; 6(3):807-818. PubMed ID: 28176469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncostatin m renders epithelial cell adhesion molecule-positive liver cancer stem cells sensitive to 5-Fluorouracil by inducing hepatocytic differentiation.
    Yamashita T; Honda M; Nio K; Nakamoto Y; Yamashita T; Takamura H; Tani T; Zen Y; Kaneko S
    Cancer Res; 2010 Jun; 70(11):4687-97. PubMed ID: 20484035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA THOR promotes liver cancer stem cells expansion via β-catenin pathway.
    Cheng Z; Lei Z; Yang P; Si A; Xiang D; Zhou J; Hüser N
    Gene; 2019 Feb; 684():95-103. PubMed ID: 30359743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP
    Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of MAGE-A9 contributes to stemness and malignancy of human hepatocellular carcinoma.
    Wei Y; Wang Y; Gong J; Rao L; Wu Z; Nie T; Shi D; Zhang L
    Int J Oncol; 2018 Jan; 52(1):219-230. PubMed ID: 29138811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An EpCAM/CD3 bispecific antibody efficiently eliminates hepatocellular carcinoma cells with limited galectin-1 expression.
    Zhang P; Shi B; Gao H; Jiang H; Kong J; Yan J; Pan X; Li K; Zhang P; Yao M; Yang S; Gu J; Wang H; Li Z
    Cancer Immunol Immunother; 2014 Feb; 63(2):121-32. PubMed ID: 24177984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma.
    Terris B; Cavard C; Perret C
    J Hepatol; 2010 Feb; 52(2):280-1. PubMed ID: 20006402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan promotes cancer progression and stem cell properties in association with Wnt signaling in colon and hepatocellular carcinoma cells.
    Chang PH; Sekine K; Chao HM; Hsu SH; Chern E
    Sci Rep; 2017 Apr; 8():45751. PubMed ID: 28367998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sorafenib suppresses extrahepatic metastasis de novo in hepatocellular carcinoma through inhibition of mesenchymal cancer stem cells characterized by the expression of CD90.
    Yoshida M; Yamashita T; Okada H; Oishi N; Nio K; Hayashi T; Nomura Y; Hayashi T; Asahina Y; Ohwada M; Sunagozaka H; Takatori H; Colombo F; Porretti L; Honda M; Kaneko S
    Sci Rep; 2017 Sep; 7(1):11292. PubMed ID: 28900199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
    Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX
    Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly tumorigenic hepatocellular carcinoma cell line with cancer stem cell-like properties.
    Lacoste B; Raymond VA; Cassim S; Lapierre P; Bilodeau M
    PLoS One; 2017; 12(2):e0171215. PubMed ID: 28152020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical Expression and Clinical Significance of Suggested Stem Cell Markers in Hepatocellular Carcinoma.
    Sung JJ; Noh SJ; Bae JS; Park HS; Jang KY; Chung MJ; Moon WS
    J Pathol Transl Med; 2016 Jan; 50(1):52-7. PubMed ID: 26581206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of fibroblast growth factor 19 and its receptor associates with progression from fatty liver to hepatocellular carcinoma.
    Li Y; Zhang W; Doughtie A; Cui G; Li X; Pandit H; Yang Y; Li S; Martin R
    Oncotarget; 2016 Aug; 7(32):52329-52339. PubMed ID: 27447573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sporadic
    Hayashi T; Yamashita T; Okada H; Nio K; Hara Y; Nomura Y; Hayashi T; Asahina Y; Yoshida M; Oishi N; Sunagozaka H; Takatori H; Honda M; Kaneko S
    Cancer Cell Int; 2017; 17():94. PubMed ID: 29075151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined Targeting of AKT and mTOR Inhibits Tumor Formation of EpCAM
    Moustafa M; Dähling KK; Günther A; Riebandt L; Smit DJ; Riecken K; Schröder C; Zhuang R; Krech T; Kriegs M; Fehse B; Izbicki JR; Fischer L; Nashan B; Li J; Jücker M
    Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
    Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J
    Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Small-molecule WNT Inhibitor, IC-2, Has the Potential to Suppress Liver Cancer Stem Cells.
    Seto K; Sakabe T; Itaba N; Azumi J; Oka H; Morimoto M; Umekita Y; Shiota G
    Anticancer Res; 2017 Jul; 37(7):3569-3579. PubMed ID: 28668848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.